There’s a big FDA stem cell meeting coming along next week that has gotten much attention, but many people didn’t realize there’s also an FDA meeting on stem cells this week too in three days on September 8th. I pasted this week’s meeting schedule at the bottom of this post from the FDA page. The meeting is […]
Wait, there’s an FDA stem cell meeting this week too? The scoop Read More »
Some good news today as the pioneering induced pluripotent stem (IPS) cell trial led by Dr. Masayo Takahashi will resume. This clinical study with a focus on macular degeneration has been on hold for quite some time due to regulatory changes in Japan. There had also been concerns over mutations in the 2nd patient’s IPS
Good stem cell news as Masayo Takahashi IPS Cell Trial to Resume Read More »
For the first time to my knowledge, a patient has sued an American stem cell clinic, US Stem Cell, alleging damage to her eyes from fat stem cell injections. Just a few months ago, there was a report of a Japanese patient who sued a fat stem cell clinic and won, but I’m not aware
US stem cell clinic sued for injection into eyes Read More »
What were the top 10 stem cell stories of the year? What were the biggest news and science headlines in the stem cell field in 2015, whether good or bad? Below are mine. What are your top 10 stem cell stories of the past year? Let us know in the comments. Organoids explode. Stem cell-based
Key stem cell stories of the year 2015 Read More »
By Heather Main This year I will be attending the World Stem Cell Summit for the first time (see @WSCSummit on Twitter). I was surprised when I looked at the program and recognized so few of the names of speakers; which made me question what this event was about, if not focused on stem cell research.
Good reasons to go to the World Stem Cell Summit Read More »
What’s better for stem cell trials such as for vision loss or Parkinson’s Disease: allogeneic or autologous cells? In a major shift earlier this year, the induced pluripotent stem (IPS) cell trial in Japan for treatment of macular degeneration (MD) switched gears from using the patients’ own cells (called “autologous”) to using banked cells from
Parkinson’s IPS cell trial in Japan switching to allogeneic Read More »
By Heather Main I was a little ashamed of myself that I didn’t know who half of the finalists were in Paul Knoepfler’s Stem Cell Person of the Year Award. I decided to look into it and find out what (or who) I have missed…..Interestingly, 3 of the 7 listed here are not scientists but
Mini-bios on finalists for Stem Cell Person of the Year Read More »
We’ve been hearing a lot this week about an important new clinical study for vision loss (macular degeneration) in the UK. This team is using retinal pigmented epithelial cells (RPEs) made from embryonic stem cells (ESC). They are now testing safety. The new work in the UK is Moorfields Eye Hospital is a great addition
New UK trial & Ocata: stem cell hope on vision impairment Read More »
The winner of the inaugural Ogawa-Yamanaka Prize is Masayo Takahashi, MD, PhD. According to the Gladstone Institute press release, “Dr. Takahashi was awarded the prize for her trailblazing work leading the first clinical trial to use induced pluripotent stem (iPS) cells in humans.” The prize, including a $150,000 cash award, will be given at a ceremony
Masayo Takahashi (高橋 政代) Receives Ogawa-Yamanaka Stem Cell Prize Read More »
I recently chatted with Sean Morrison, current President of ISSCR, on his goals for the Society, where the stem cell field stands today, top challenges, and the future. 2020 update: read my new interview with Sean on cell therapies for COVID-19. What are your goals for your tenure as President of ISSCR? SM: ISSCR is the
ISSCR President Sean Morrison on challenges and future of stem cell field Read More »